問：國際婦產(chǎn)科超聲學(xué)會(huì)的性質(zhì)和宗旨,？

問：如何確定胎兒大??？

問：小于胎齡兒是如何定義的,？

問：胎兒生長(zhǎng)受限的定義？

問：小于胎齡兒和胎兒生長(zhǎng)受限之間的主要區(qū)別是什么,？

問：在胎兒大小低于第10百分位數(shù)的情況下,，有什么方法可以鑒別小于胎齡兒和胎兒生長(zhǎng)受限,？

問：評(píng)估胎兒生長(zhǎng)速度的方法有哪些？

問：制定胎兒生長(zhǎng)曲線依據(jù)了哪些因素？有何建議,？

問：多普勒測(cè)速儀應(yīng)用于胎兒生長(zhǎng)評(píng)估的基本原理？

問：子宮胎盤功能不全的可能原因？

問：多普勒測(cè)速是怎么評(píng)估胎兒的,？

問：子宮動(dòng)脈阻力與胎盤功能不全有關(guān)嗎,？

問：臍動(dòng)脈搏動(dòng)指數(shù)與胎盤功能不全有何關(guān)系,？

問：什么是“腦保護(hù)”效應(yīng),？有何臨床意義,？

問：靜脈導(dǎo)管中a波缺失或反向是什么原因?qū)е碌模?/strong>

問：多普勒檢查技術(shù)對(duì)胎兒生長(zhǎng)受限的臨床診療有何作用,？

問：胎兒生物物理評(píng)分包括哪些項(xiàng)目的評(píng)估,？

問：胎兒生物物理評(píng)分對(duì)評(píng)估胎兒狀況有何價(jià)值,？

問：胎兒低氧血癥時(shí)胎心監(jiān)護(hù)和胎心率短期變異有何改變,？

問：有沒有測(cè)量胎兒心率的客觀方法,？

問：有用于篩查,、診斷和管理小于胎齡兒和胎兒生長(zhǎng)受限的生物學(xué)指標(biāo)嗎？

問：胎兒生長(zhǎng)受限有幾種主要表型,？

問：區(qū)別早發(fā)型和晚發(fā)型胎兒生長(zhǎng)受限的主要標(biāo)準(zhǔn)是什么？

問：目前最受認(rèn)可的胎兒生長(zhǎng)受限定義是哪個(gè)？

問：對(duì)于多普勒測(cè)速技術(shù)有普遍的共識(shí)嗎,？

問：為什么胎兒大腦中動(dòng)脈和臍動(dòng)脈多普勒指數(shù)報(bào)告存在參考范圍的差異,？

問：定義胎兒生長(zhǎng)受限的多普勒標(biāo)準(zhǔn)是什么,？

問：應(yīng)該如何認(rèn)識(shí)這些差異的存在,？

問：早發(fā)型胎兒生長(zhǎng)受限的病因？

問：早發(fā)型胎兒生長(zhǎng)受限早期改變時(shí)哪項(xiàng)指標(biāo)最先出現(xiàn)異常,？

問：早發(fā)型胎兒生長(zhǎng)受限的晚期表現(xiàn),？

問：胎兒生長(zhǎng)受限有沒有有效的治療方法,？

問：早發(fā)型胎兒生長(zhǎng)受限臨床管理的關(guān)鍵點(diǎn)是什么？

問：早發(fā)型胎兒生長(zhǎng)受限應(yīng)如何監(jiān)測(cè),？

問：應(yīng)多久監(jiān)測(cè)一次胎兒臍動(dòng)脈多普勒檢查,？

問：可以根據(jù)大腦中動(dòng)脈多普勒結(jié)果確定分娩時(shí)機(jī)嗎,？

問：母體胎盤生長(zhǎng)因子在胎兒生長(zhǎng)受限診斷和管理中有價(jià)值嗎？

問：早發(fā)型胎兒生長(zhǎng)受限患者需要糖皮質(zhì)激素促胎肺成熟治療嗎,？

問：胎兒生長(zhǎng)受限患者也需要應(yīng)用硫酸鎂進(jìn)行胎兒神經(jīng)保護(hù)治療嗎,？

問：對(duì)早發(fā)型胎兒生長(zhǎng)受限的新生兒結(jié)局產(chǎn)生不利影響的主要量化參數(shù)是什么,？

問：早發(fā)型胎兒生長(zhǎng)受限的最佳分娩時(shí)機(jī)是何時(shí)？基于何種證據(jù),？

參考文獻(xiàn)

1

Miller SL, Huppi PS, Mallard C. The consequences of fetal growth restriction on brain structure and neurodevelopmental outcome. J Physiol 2016; 594: 807–823.

2

Francis JH, Permezel M, Davey MA. Perinatal mortality by birthweight centile.Aust N Z J Obstet Gynecol 2014; 54: 354–359.

3

Barker DJ, Osmond C, Fors′en TJ, Kajantie E, Eriksson JG. Trajectories of growth among children who have coronary events as adults. N Engl J Med 2005; 353:1802–1809.

4

Flenady V, Wojcieszek AM, Middleton P, Ellwood D, Erwich JJ, Coory M, Khong TY, Silver RM, Smith GC, Boyle FM, Lawn JE, Blencowe H, Leisher SH, Gross MM, Horey D, Farrales L, Bloomfield F, McCowan L, Brown SJ, Joseph KS, Zeitlin J, Reinebrant HE, Ravaldi C, Vannacci A, Cassidy J, Cassidy P, Farquhar C,Wallace E, Siassakos D, Heazell AE, Storey C, Sadler L, Petersen S, Fr?en JF, Goldenberg RL, Lancet Ending Preventable Stillbirths study group; Lancet Stillbirths InHigh-Income Countries Investigator Group. Stillbirths: recall to action in high-income countries. Lancet 2016; 387: 691–702.

5

Nohuz E, Rivi`ere O, Coste K, Vendittelli F. Prenatal identification of small-for-gestational-age and risk of neonatal morbidity and stillbirth. Ultrasound Obstet Gynecol 2020; 55: 621–628.

6

Salomon LJ, Alfirevic Z, Da Silva Costa F, Deter RL, Figueras F, Ghi T, Glanc P, Khalil A, LeeW, Napolitano R, Papageorghiou A, Sotiriadis A, Stirnemann J, Toi A, Yeo G. ISUOG Practice Guidelines: ultrasound assessment of fetal biometry and growth. Ultrasound Obstet Gynecol 2019; 53: 715–723.

7

Poon LC, Tan MY, Yerlikaya G, Syngelaki A, Nicolaides KH. Birth weight in live births and stillbirths. Ultrasound Obstet Gynecol 2016; 48: 602–606.

8

Bligh LN, Flatley CJ, Kumar S. Reduced growth velocity at term is associated with adverse neonatal outcomes in non-small for gestational age infants. Eur J Obstet Gynecol Reprod Biol 2019; 240: 125–129.

9

Morales-Rosell ′o J, Khalil A, Morlando M, Papageorghiou A, Bhide A, Thilaganathan B. Changes in fetal Doppler indices as a marker of failure to reach growth potential at term. Ultrasound Obstet Gynecol 2014; 43: 303–310.

10

Prior T, Paramasivam G, Bennett P, Kumar S. Are fetuses that fail to achieve their growth potential at increased risk of intrapartum compromise? Ultrasound Obstet Gynecol 2015; 46: 460–464.

11

Sovio U, White IR, Dacey A, Pasupathy D, Smith GCS. Screening for fetal growth restriction with universal third trimester ultrasonography in nulliparous women in the Pregnancy Outcome Prediction (POP) study: a prospective cohort study. Lancet 2015; 386: 2089–2097.

12

Moraitis AA, Wood AM, Fleming M, Smith GC. Birth weight percentile and the risk of term perinatal death. Obstet Gynecol 2014; 124: 274–283.

13

Vasak B, Koenen SV, Koster MP, Hukkelhoven CW, Franx A, Hanson MA, Visser GH. Human fetal growth is constrained below optimal for perinatal survival. Ultrasound Obstet Gynecol 2015; 45: 162–167.

14

McIntire DD, Bloom SL, Casey BM, Leveno KJ. Birth weight in relation to morbidity and mortality among newborn infants. N Engl J Med 1999; 340: 1234–1238.

15

Gardosi J, Madurasinghe V, Williams M, Malik A, Francis A. Maternal and fetal risk factors for stillbirth: population based study. BMJ 2013; 346: f108.

16

Gordijn SJ, Beune IM, Thilaganathan B, Papageorghiou A, Baschat AA, Baker PN, Silver RM, Wynia K, Ganzevoort W. Consensus definition of fetal growth restriction: a Delphi procedure. Ultrasound Obstet Gynecol 2016; 48: 333–339.

17

Iliodromiti S, Mackay DF, Smith GC, Pell JP, Sattar N, Lawlor DA, Nelson SM. Customised and Noncustomised Birth Weight Centiles and Prediction of Stillbirth and Infant Mortality and Morbidity: A Cohort Study of 979,912 Term Singleton Pregnancies in Scotland. PLoS Med 2017; 14: e1002228.

18

Royston P, Altman DG. Design and analysis of longitudinal studies of fetal size. Ultrasound Obstet Gynecol 1995; 6: 307–312.

19

Deter RL, LeeW, Yeo L, Erez O, Ramamurthy U,NaikM, Romero R. Individualized growth assessment: conceptual framework and practical implementation for the evaluation of fetal growth and neonatal growth outcome. Am J Obstet Gynecol 2018; 218: S656–678.

20

MacDonald TM, Hui L, Tong S, Robinson AJ, Dane KM, Middleton AL, Walker SP. Reduced growth velocity across the third trimester is associated with placental insufficiency in fetuses born at a normal birthweight: a prospective cohort study. BMC Med 2017; 15: 164.

21

Levytska K, Higgins M, Keating S,Melamed N, Walker M, Sebire NJ, Kingdom JC. Placental Pathology in Relation to Uterine Artery Doppler Findings in Pregnancies with Severe Intrauterine Growth Restriction and Abnormal Umbilical Artery Doppler Changes. Am J Perinatol 2017; 34: 451–457.

22

Burton GJ, Woods AW, Jauniaux E, Kingdom JC. Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy. Placenta 2009; 30: 473–482.

23

Richardson BS, Bocking AD. Metabolic and circulatory adaptations to chronic hypoxia in the fetus. Comp Biochem Physiol A Mol Integr Physiol 1998; 119:717–723.

24

Kiserud T, Kessler J, Ebbing C, Rasmussen S. Ductus venosus shunting in growth-restricted fetuses and the effect of umbilical circulatory compromise. Ultrasound Obstet Gynecol 2006; 28: 143–149.

25

Ferrazzi E, Lees C, Acharya G. The controversial role of the ductus venosus in hypoxic human fetuses. Acta Obstet Gynecol Scand 2019; 98: 823–829.

26

Manning FA, Snijders R, Harman CR, Nicolaides K, Menticoglou S, Morrison I. Fetal biophysical profile score. VI. Correlation with antepartum umbilical venous fetal pH. Am J Obstet Gynecol 1993; 169: 755–763.

27

Turan S, Turan OM, Berg C, Moyano D, Bhide A, Bower S, Thilaganathan B, Gembruch U, Nicolaides K, Harman C, Baschat AA. Computerized fetal heart rate analysis, Doppler ultrasound and biophysical profile score in the prediction of acid-base status of growth-restricted fetuses. Ultrasound Obstet Gynecol 2007; 30: 750–756.

28

Nageotte MP, Towers CV, Asrat T, Freeman RK. Perinatal outcome with the modified biophysical profile. Am J Obstet Gynecol 1994; 170: 1672–1676.

29

Baschat AA. Planning management and delivery of the growth-restricted fetus. Best Pract Res Clin Obstet Gynaecol 2018; 49: 53–65.

30

Whigham CA, MacDonald TM, Walker SP, Hannan NJ, Tong S, Kaitu’u-Lino TJ. The untapped potential of placenta-enriched molecules for diagnostic and therapeutic development. Placenta 2019; 84: 28–31.

31

Zhong Y, Zhu F, Ding Y. Serum screening in first trimester to predict pre-eclampsia, small for gestational age and preterm delivery: systematic review and meta-analysis. BMC Pregnancy Childbirth 2015; 15: 191.

32

Proctor LK, Toal M, Keating S, Chitayat D, Okun N, Windrim RC, Smith GC, Kingdom JC. Placental size and the prediction of severe early-onset intrauterine growth restriction in women with low pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 2009; 34: 274–282.

33

Zeisler H, Llurba E, Chantraine F, Vatish M, Staff AC, Sennstr ¨om M, Olovsson M, Brennecke SP, Stepan H, Allegranza D, Dilba P, Schoedl M, Hund M, Verlohren S. Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia. N Engl J Med 2016; 374: 13–22.

34

Gaccioli F, Sovio U, Cook E, Hund M, Charnock-Jones DS, Smith GCS. Screening for fetal growth restriction using ultrasound and the sFLT1/PlGF ratio in nulliparous women: a prospective cohort study. Lancet Child AdolescHealth 2018; 2: 569–581.

35

Griffin M, Seed PT, Webster L, Myers J, MacKillop L, Simpson N, Anumba D, Khalil A, Denbow M, Sau A, Hinshaw K, von Dadelszen P, Benton S, Girling J, Redman CW, Chappell LC, Shennan AH. Diagnostic accuracy of placental growth factor and ultrasound parameters to predict the small-for-gestational-age infant in women presenting with reduced symphysis-fundus height. Ultrasound Obstet Gynecol 2015; 46: 182–190.

36

Kwiatkowski S, Bednarek-J ?edrzejek M, Ksel J, Tousty P, Kwiatkowska E, Cymbaluk A, Rzepka R, Chudecka-G?az A, Do? ?egowska B, Torb`e A. sFlt-1/PlGF and Doppler ultrasound parameters in SGA pregnancies with confirmed neonatal birth weight below 10th percentile. Pregnancy Hypertens 2018; 14: 79–85.

37

Herraiz I, Quezada MS, Rodriguez-Calvo J, G′ omez-Montes E, Villala′?n C, Galindo A. Longitudinal change of sFlt-1/PlGF ratio in singleton pregnancy with early-onset fetal growth restriction. Ultrasound Obstet Gynecol 2018; 52: 631–638.

38

Fabjan-Vodusek V, Kumer K, Osredkar J, Verdenik I, Gersak K, Premru-Srsen T. Correlation between uterine artery Doppler and the sFlt-1/PlGF ratio in different phenotypes of placental dysfunction. Hypertens Pregnancy 2019; 38: 32–40.

39

Crimmins S, Desai A, Block-Abraham D, Berg C, Gembruch U, Baschat AA. A comparison of Doppler and biophysical findings between liveborn and stillborn growth-restricted fetuses. Am J Obstet Gynecol 2014; 211: 669.e1–10.

40

Savchev S, Figueras F, Sanz-Cortes M, Cruz-Lemini M, Triunfo S, Botet F, Gratacos E. Evaluation of an optimal gestational age cut-off for the definition of early- and late-onset fetal growth restriction. Fetal Diagn Ther 2014; 36: 99–105.

41

Mifsud W, Sebire NJ. Placental pathology in early-onset and late-onset fetal growth restriction. Fetal Diagn Ther 2014; 36: 117–128.

42

Figueras F, Gratacos E. Stage-based approach to the management of fetal growth restriction. Prenat Diagn 2014; 34: 655–659.

43

McCowan LM, Figueras F, Anderson NH. Evidence-based national guidelines for the management of suspected fetal growth restriction: comparison, consensus, and controversy. Am J Obstet Gynecol 2018; 218: S855–868.

44

Molina LCG, Odibo L, Zientara S, Obican SG, Rodriguez A, Stout M, Odibo AO. Validation of Delphi procedure consensus criteria for defining fetal growth restriction. Ultrasound Obstet Gynecol 2020; 56: 61–66.

45

Bhide A, Acharya G, Bilardo CM, Brezinka C, Cafici D, Hernandez-Andrade E, Kalache K, Kingdom J, Kiserud T, Lee W, Lees C, Leung KY, Malinger G, Mari G, Prefumo F, Sepulveda W, Trudinger B. ISUOG practice guidelines: use of Doppler ultrasonography in obstetrics. Ultrasound Obstet Gynecol 2013; 41: 233–239.

46

Oros D, Ruiz-Martinez S, Staines-Urias E, Conde-Agudelo A, Villar J, Fabre E, Papageorghiou AT. Reference ranges for Doppler indices of umbilical and fetal middle cerebral arteries and cerebroplacental ratio: systematic review. Ultrasound Obstet Gynecol 2019; 53: 454–464.

47

Ruiz-Martinez S, Papageorghiou AT, Staines-Urias E, Villar J, Gonzalez De Ag¨ uero R, Oros D. Clinical impact of Doppler reference charts on management of small-for-gestational-age fetuses: need for standardization. Ultrasound Obstet Gynecol 2020; 56: 166–172.

48

Stampalija T, Ghi T, Rosolen V, Rizzo G, Ferrazzi EM, Prefumo F, Dall’Asta A, Quadrifoglio M, Todros T, Frusca T; on behalf of SIEOG working group on fetal biometric charts. Current use and performance of the different fetal growth charts in the Italian population. Eur J Obstet Gynecol Reprod Biol 2020. DOI: 10.1016/j .ejogrb.2020.06.059.

49

Vollgraff Heidweiller-Schreurs CA, De Boer MA, Heymans MW, Schoonmade LJ, Bossuyt PMM, Mol BWJ, De Groot CJM, Bax CJ. Prognostic accuracy of cerebroplacental ratio and middle cerebral artery Doppler for adverse perinatal outcome: systematic review and meta-analysis. Ultrasound Obstet Gynecol 2018; 51: 313–322.

50

Hecher K, Spernol R, Stettner H, Szalay S. Potential for diagnosing imminent risk to appropriate- and small-for-gestational-age fetuses by Doppler sonographic examination of umbilical and cerebral arterial blood flow. Ultrasound Obstet Gynecol 1992; 2: 266–271.

51

Conde-Agudelo A, Villar J, Kennedy SH, Papageorghiou AT. Predictive accuracy of cerebroplacental ratio for adverse perinatal and neurodevelopmental outcomes in suspected fetal growth restriction: systematic review and meta-analysis. Ultrasound Obstet Gynecol 2018; 52: 430–441.

52

Stampalija T, Arabin B, Wolf H, Bilardo CM, Lees C; TRUFFLE investigators. Is middle cerebral artery Doppler related to neonatal and 2-year infant outcome in early fetal growth restriction? Am J Obstet Gynecol 2017; 216: 521.e1–13.

53

Ogge G, Chaiworapongsa T, Romero R, Hussein Y, Kusanovic JP, Yeo L, Kim CJ, Hassan SS. Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsia. J Perinat Med 2011; 39: 641–652.

54

Egbor M, Ansari T, Morris N, Green CJ, Sibbons PD. Morphometric placental villous and vascular abnormalities in early- and late-onset pre-eclampsia with and without fetal growth restriction. BJOG 2006; 113: 580–589.

55

Baschat AA, Cosmi E, Bilardo CM, Wolf H, Berg C, Rigano S,Germer U,MoyanoD, Turan S, Hartung J, Bhide A, M¨ uller T, Bower S, Nicolaides KH, Thilaganathan B, Gembruch U, Ferrazzi E, Hecher K, Galan HL, Harman CR. Predictors of neonatal outcome in early-onset placental dysfunction. Obstet Gynecol 2007; 109: 253–261.

56

Ferrazzi E, Bozzo M, Rigano S, Bellotti M, Morabito A, Pardi G, Battaglia FC, Galan HL. Temporal sequence of abnormal Doppler changes in the peripheral and central circulatory systems of the severely growth-restricted fetus. Ultrasound Obstet Gynecol 2002; 19: 140–146.

57

Hecher K, Bilardo CM, Stigter RH, Ville Y, Hackel ¨ oer BJ, Kok HJ, Senat MV, Visser GH. Monitoring of fetuses with intrauterine growth restriction: a longitudinal study. Ultrasound Obstet Gynecol 2001; 18: 564–570.

58

Baschat AA, Kush M, Berg C, Gembruch U, Nicolaides KH, Harman CR, Turan OM. Hematologic profile of neonates with growth restriction is associated with rate and degree of prenatal Doppler deterioration. Ultrasound Obstet Gynecol 2013; 41: 66–72.

59

Baschat AA, Gembruch U, Harman CR. The sequence of changes in Doppler and biophysical parameters as severe fetal growth restriction worsens. Ultrasound Obstet Gynecol 2001; 18: 571–577.

60

Cosmi E, Ambrosini G, D’Antona D, Saccardi C, Mari G. Doppler, cardiotocography, and biophysical profile changes in growth-restricted fetuses. Obstet Gynecol 2005; 106: 1240–1245.

61

Ting JY, Kingdom JC, Shah PS. Antenatal glucocorticoids, magnesium sulfate, and mode of birth in preterm fetal small for gestational age. Am J Obstet Gynecol 2018; 218: S818–828.

62

Raju TNK, Mercer BM, Burchfield DJ, Joseph GF Jr. Periviable birth: executive summary of a joint workshop by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, Society for Maternal-Fetal Medicine, American Academy of Pediatrics, and American College of Obstetricians and Gynecologists. Obstet Gynecol 2014; 123: 1083–1096.

63

EXPRESS Group. Incidence of and risk factors for neonatal morbidity after active perinatal care: extremely preterm infants study in Sweden (EXPRESS). Acta Paediatr 2010; 99: 978–992.

64

Torrance HL, Bloemen MC, Mulder EJ, Nikkels PG, Derks JB, de Vries LS, Visser GH. Predictors of outcome at 2 years of age after early intrauterine growth restriction. Ultrasound Obstet Gynecol 2010; 36: 171–177.

65

Morsing E, Asard M, Ley D, Stjernqvist K, Mars ′ al K. Cognitive function after intrauterine growth restriction and very preterm birth. Pediatrics 2011; 127: e874–882.

66

Bilardo CM, Hecher K, Visser GHA, Papageorghiou AT, Marlow N, Thilaganathan B, Van Wassenaer-Leemhuis A, Todros T, Marsal K, Frusca T, Arabin B, Brezinka C, Derks JB, Diemert A, Duvekot JJ, Ferrazzi E, Ganzevoort W, Martinelli P, Ostermayer E, Schlembach D, Valensise H, Thornton J, Wolf H, Lees C; TRUFFLE Group. Severe fetal growth restriction at 26-32 weeks: key messages from the TRUFFLE study. Ultrasound Obstet Gynecol 2017; 50: 285–290.

67

Royal College of Obstetricians and Gynaecologists. Small-for-Gestational-Age Fetus, Investigation and Management (Green-top Guideline No. 31). 2013. https://www./globalassets/documents/guidelines/gtg_31.pdf

68

Lees C, Marlow N, Arabin B, Bilardo CM, Brezinka C, Derks JB, Duvekot J, Frusca T, Diemert A, Ferrazzi E, Ganzevoort W, Hecher K, Martinelli P, Ostermayer E, Papageorghiou AT, Schlembach D, Schneider KT, Thilaganathan B, Todros T, van Wassenaer-Leemhuis A, Valcamonico A, Visser GH, Wolf H; TRUFFLE Group. Perinatal morbidity and mortality in early-onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE). Ultrasound Obstet Gynecol 2013; 42: 400–408.

69

Duhig KE, Myers J, Seed PT, Sparkes J, Lowe J, Hunter RM, Shennan AH, Chappell LC; PARROT trial group. Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial. Lancet 2019; 393: 1807–1818.

70

American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins-Obstetrics and the Society for Maternal-Fetal Medicine. ACOG Practice Bulletin No. 204: Fetal Growth Restriction. Obstet Gynecol 2019; 133: e97–109.

71

Lausman A, McCarthy FP, Walker M, Kingdom J. Screening, diagnosis, and management of intrauterine growth restriction. J Obstet Gynaecol Can 2012; 34: 17–28.

72

Institute of Obstetricians and Gynaecologists, Royal College of Physicians of Ireland and Directorate of Clinical Strategy and Programmes, Health Service Executive. Guideline No 28. Fetal growth restriction - recognition, diagnosis & management. 2017. https://www./eng/services/publications/clinical-strategyand-programmes/fetal-growth-restriction.pdf

73

Vayssi`ere C, Sentilhes L, Ego A, Bernard C, Cambourieu D, Flamant C, Gascoin G, Gaudineau A, Grang′e G, Houfflin-Debarge V, Langer B, Malan V, Marcorelles P, Nizard J, Perrotin F, Salomon L, Senat MV, Serry A, Tessier V, Truffert P, Tsatsaris V, Arnaud C, Carbonne B. Fetal growth restriction and intra-uterine growth restriction: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians. Eur J Obstet Gynecol Reprod Biol 2015; 193: 10–18.

74

New Zealand Maternal Fetal Medicine Network. Guideline for the management of suspected small for gestational age singleton pregnancies and infants after 34weeks’gestation. New Zealand Maternal Fetal Medicine Network; 2014.

75

Magann EF, Haram K, Ounpraseuth S, Mortensen JH, Spencer HJ, Morrison JC. Use of antenatal corticosteroids in special circumstances: a comprehensive review. Acta Obstet Gynecol Scand 2017; 96: 395–409.

76

SimchenMJ, Alkazaleh F, Adamson SL,Windrim R, Telford J, Beyene J, Kingdom J. The fetal cardiovascular response to antenatal steroids in severe early-onset intrauterine growth restriction. Am J Obstet Gynecol 2004; 190: 296–304.

77

Wolf HT, Huusom LD, Henriksen TB, Hegaard HK, Brok J, Pinborg A.Magnesium sulphate for fetal neuroprotection at imminent risk for preterm delivery: a systematic review with meta-analysis and trial sequential analysis. BJOG 2020. DOI: 10.1111/1471-0528.16238.

78

Antenatal Magnesium Sulfate for Neuroprotection Guideline Development Panel. Antenatal Magnesium Sulphate Prior to Preterm Birth for Neuroprotection of the Fetus, Infant and Child. Adelaide: University of Adelaide, Australia 2010. https://cdn./assets/liggins/docs/Antenatal%20magnesium%20sulphate%20prior%20to%20preterm%20birth%20for%20neuroprotection%20of%20the%20fetus,%20infant%20&%20child,%20National%20clinical%20practice%20guidelines.pdf

79

Stockley EL, Ting JY, Kingdom JC, McDonald SD, Barrett JF, Synnes AR, Monterrosa L, Shah PS; Canadian Neonatal Network; Canadian Neonatal Follow-up Network; Canadian Preterm Birth Network Investigators. Intrapartum magnesium sulfate is associated with neuroprotection in growth-restricted fetuses. Am J Obstet Gynecol 2018; 219: 606.e1–8.

80

GRIT Study Group. A randomised trial of timed delivery for the compromised preterm fetus: short term outcomes and Bayesian interpretation. BJOG 2003; 110: 27–32.

81

Thornton JG, Hornbuckle J, Vail A, Spiegelhalter DJ, LeveneM; GRIT study group. Infant wellbeing at 2 years of age in the Growth Restriction Intervention Trial(GRIT): multicentred randomised controlled trial. Lancet 2004; 364: 513–520.

82

Walker DM, Marlow N, Upstone L, Gross H, Hornbuckle J, Vail A, Wolke D, Thornton JG. The Growth Restriction Intervention Trial: long-term outcomes in a randomized trial of timing of delivery in fetal growth restriction. Am J Obstet Gynecol 2011; 204: 34.e1–9.

83

Lees CC, Marlow N, van Wassenaer-Leemhuis A, Arabin B, Bilardo CM, Brezinka C, Calvert S, Derks JB, Diemert A, Duvekot JJ, Ferrazzi E, Frusca T, Ganzevoort W, Hecher K, Martinelli P, Ostermayer E, Papageorghiou AT, Schlembach D, Schneider KT, Thilaganathan B, Todros T, Valcamonico A, Visser GH, Wolf H; TRUFFLE study group. 2 year neurodevelopmental and intermediate perinatal outcomes in infants with very preterm fetal growth restriction (TRUFFLE): a randomised trial. Lancet 2015; 385: 2162–2172.